References
- Sharma HS, Westman J. Blood–Spinal Cord and Brain Barriers in Health and Diseases. Elsevier Academic Press, CA, USA (2004).
- Oertle T, Schwab ME. Nogo and its paRTNers. Trends Cell Biol.13(4), 187–194 (2003).
- Almeida OF, Conde GL, Crochemore C et al. Subtle shifts in the ratio between pro-and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J.14(5), 779–790 (2000).
- Wang JY, Wen LL, Huang YN, Chen YT, Ku MC. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr. Pharm. Des.12(27), 3521–3533 (2006).
- Sharma HS, Johanson CE. Blood–cerebrospinal fluid barrier in hyperthermia. Prog. Brain Res.162, 461–480 (2007).
- Sharma HS. Pathophysiology of blood–spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des.11(11), 1353–1389 (2005).
- Rapoport SI. Blood–Brain Barrier in Physiology and Medicine. Pergamon Press, NY, USA (1976).
- Sharma HS. Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches. J. Neural Transm.113(4), 497–519 (2006).
- Leech S, Kirk J, Plumb J, McQuaid S. Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol.33(1), 86–98 (2007).